• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Decision Diagnostics

MedTech 100 roundup: Slight rise for the industry

March 29, 2021 By Sean Whooley

While medtech’s performance still isn’t mirroring the beginning of 2021, the industry is showing signs of life with a small improvement last week. The year’s strong start, during which MassDevice‘s MedTech 100 index notched an all-time best of 110.96 points (Feb. 15) came to an end later that month and carried over into March, with the […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Mergers & Acquisitions, Wall Street Beat Tagged With: 7D Surgical, Biocorp, Boston Scientific, coronavirus, COVID-19, Decision Diagnostics, Dexcom, Diabeloop, MedTech 100 Index, Personnel Moves, Pixium Vision, SeaSpine, Second Sight

Investors sue Decision Diagnostics over COVID-19 test

March 22, 2021 By Sean Whooley

Decision Diagnostics is facing legal action after the company allegedly misled investors about developing a COVID-19 diagnostic. Licgo Partners, Sovereign Partners and Paradigm Capital, all investor companies, sued Decision Diagnostics and CEO Keith Berman in federal court under allegations that Berman had falsely stated that the company was developing an at-home COVID-19 test that was […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Legal News Tagged With: coronavirus, COVID-19, Decision Diagnostics

SEC charges diagnostics company with fraud over COVID-19 test claims

December 21, 2020 By Sean Whooley

The SEC announced charges against Decision Diagnostics (OTCMKTS:DECN) and its CEO, alleging false and misleading claims over a COVID-19 blood test. Westlake Village, Calif.-based Decision Diagnostics and its CEO Keith Berman are alleged to have made the claims in numerous press releases, saying that the company had developed a working, breakthrough technology for detecting COVID-19 […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Legal News Tagged With: coronavirus, COVID-19, Decision Diagnostics, Securities & Exchange Commission (SEC)

Decision Diagnostics sues J&J’s LifeScan over glucose test strip patents

March 16, 2016 By Fink Densford

Decision Diagnostics (OTC:DECN) said today its subsidiaries Decision IT and Pharma Tech Solutions filed a lawsuit against Johnson & Johnson (NYSE:JNJ) and its Lifescan divisions over patent infringement related to glucose testing strips, looking for compensation between $400 and $700 million. The Los Angeles-based company said the patent infringement case centers around 3 features and 2 […]

Filed Under: Diabetes, Legal News Tagged With: Decision Diagnostics

Decision Dx wins test strip patent challenge to J&J’s LifeScan

January 21, 2016 By Brad Perriello

A federal appeals court yesterday upheld a U.S. Patent & Trademark Office decision that a blood glucose testing patent owned by JNJ subisidary LifeScan is invalid. The U.S. Court of Appeals for the Federal Circuit’s per curiam decision, issued without comment, was a win for Decision Diagnostics (OTC:DECN) subsidiary PharmaTech Solutions and its GenStrip 50 test strip. […]

Filed Under: Diabetes, Legal News, Patent Infringement Tagged With: Decision Diagnostics, Johnson and Johnson, LifeScan Inc., PharmaTech Solutions

Diabetes: J&J loses a round in glucose testing battle with Shasta

November 7, 2013 By Arezu Sarvestani Leave a Comment

Diabetes: J&J loses a round in glucose testing battle with Shasta

Filed Under: Diagnostics, Legal News, News Well, Patent Infringement Tagged With: Decision Diagnostics, Johnson and Johnson, LifeScan Inc., Shasta Technologies

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS